Summary of opinion: Iclusig, 21/05/2026 Positive
Submitted by Anonymous (not verified) on 22 May 2026 - 11:36
Summary of opinion: Iclusig, 21/05/2026 Positive
Summary of opinion: Tepkinly, 21/05/2026 Positive
Submitted by Anonymous (not verified) on 22 May 2026 - 11:36
Summary of opinion: Tepkinly, 21/05/2026 Positive
Human medicines European public assessment report (EPAR): Colchicine Agepha Pharma, colchicine, Status: Opinion
Submitted by Anonymous (not verified) on 22 May 2026 - 11:35
Human medicines European public assessment report (EPAR): Colchicine Agepha Pharma, colchicine, Status: Opinion
Orphan designation: bevacizumab Treatment of hereditary haemorrhagic telangiectasia, 16/12/2014 Positive
Submitted by Anonymous (not verified) on 22 May 2026 - 11:32
Orphan designation: bevacizumab Treatment of hereditary haemorrhagic telangiectasia, 16/12/2014 Positive
Orphan designation: alpelisib Treatment of PIK3CA related overgrowth spectrum, 26/03/2021 Positive
Submitted by Anonymous (not verified) on 22 May 2026 - 11:32
Orphan designation: alpelisib Treatment of PIK3CA related overgrowth spectrum, 26/03/2021 Positive
Orphan designation: Copper (64Cu) oxodotreotide Diagnosis of neuroendocrine neoplasms, 09/12/2022 Positive
Submitted by Anonymous (not verified) on 22 May 2026 - 11:32
Orphan designation: Copper (64Cu) oxodotreotide Diagnosis of neuroendocrine neoplasms, 09/12/2022 Positive
New medicine for two types of pulmonary fibrosis
Submitted by Anonymous (not verified) on 22 May 2026 - 11:00
New medicine for two types of pulmonary fibrosis
First medicine to treat rare uncontrolled growth of body tissues
Submitted by Anonymous (not verified) on 22 May 2026 - 11:00
First medicine to treat rare uncontrolled growth of body tissues
First oral GLP-1 treatment for weight management
Submitted by Anonymous (not verified) on 22 May 2026 - 11:00
First oral GLP-1 treatment for weight management
Overview of (invented) names reviewed in April 2026 by the Name Review Group (NRG) adopted at the CHMP meeting of 21 May 2026
Submitted by Anonymous (not verified) on 22 May 2026 - 11:00
Overview of (invented) names reviewed in April 2026 by the Name Review Group (NRG) adopted at the CHMP meeting of 21 May 2026